Ready, I'm pretty sure the company will not be able to speak to the media about Direct until Ph I results come out at ASCO (though, I believe the rules do allow for PR of the Ph I results, but not much else).
I suspect they will not not need me one iota soon. ;)
If they're able to reduce one injected tumor by >35+%and others by >5+% in >25+% of patients (realize it may be closer to 55%) in various late stage cancers, I'm pretty sure the market will be thinking what I will be thinking, which is "wow, imagine what will happen when they inject multiple tumors!"
The media will be knocking on their door, the world will want to hear more. :)
News 
Market Data 
Discover 
